Impala Asset Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-220,500
Closed -$10.6M 39
2021
Q4
$10.6M Sell
220,500
-55,102
-20% -$2.47M 0.83% 29
2021
Q3
$11.4M Sell
275,602
-593,496
-68% -$23.7M 0.81% 36
2021
Q2
$39.3M Buy
869,098
+611
+0.1% +$28.6K 2.62% 12
2021
Q1
$38.4M Buy
868,487
+413,560
+91% +$15.6M 2.52% 12
2020
Q4
$15.8M Sell
454,927
-145,342
-24% -$4.1M 1.43% 28
2020
Q3
$10.4M Sell
600,269
-282,980
-32% -$4.93M 1.05% 30
2020
Q2
$14.5M Buy
+883,249
New +$13.4M 1.66% 22

Other funds holding ADNT

Impala Asset Management's ADNT Position: Q1 2022 in Review

Impala Asset Management sold out of Adient (ADNT) in Q1 2022, closing a stake of 220,500 shares — an estimated $10.6M sold.

Impala Asset Management first reported a position in ADNT in Q2 2020 and held it in 7 quarters. The position peaked at $39.3M in Q2 2021. 270 funds tracked by Wall St. Rank hold ADNT as of Q1 2022.

  • Impala Asset Management reported no remaining Adient position as of Q1 2022 after selling out during the quarter.
  • Impala Asset Management sold 220,500 Adient shares in Q1 2022, an estimated $10.6M.
  • Impala Asset Management first reported a position in Adient in Q2 2020 and held it in 7 quarters.
  • Impala Asset Management's Adient position peaked at $39.3M in Q2 2021.
  • 270 funds tracked by Wall St. Rank held Adient as of Q1 2022.

Based on Impala Asset Management's 13F filing for Q1 2022, filed 13 May 2022.